Titre : Chromosomes humains de la paire 15

Chromosomes humains de la paire 15 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 15 : Questions médicales les plus fréquentes", "headline": "Chromosomes humains de la paire 15 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chromosomes humains de la paire 15 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-05", "dateModified": "2025-02-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 15" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Chromosomes humains 13-15", "url": "https://questionsmedicales.fr/mesh/D002901", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains 13-15", "code": { "@type": "MedicalCode", "code": "D002901", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.370" } } }, "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 15", "alternateName": "Chromosomes, Human, Pair 15", "code": { "@type": "MedicalCode", "code": "D002884", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Arang Rhie", "url": "https://questionsmedicales.fr/author/Arang%20Rhie", "affiliation": { "@type": "Organization", "name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA." } }, { "@type": "Person", "name": "Sergey Koren", "url": "https://questionsmedicales.fr/author/Sergey%20Koren", "affiliation": { "@type": "Organization", "name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA." } }, { "@type": "Person", "name": "Erik Garrison", "url": "https://questionsmedicales.fr/author/Erik%20Garrison", "affiliation": { "@type": "Organization", "name": "Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA." } }, { "@type": "Person", "name": "Jennifer L Gerton", "url": "https://questionsmedicales.fr/author/Jennifer%20L%20Gerton", "affiliation": { "@type": "Organization", "name": "Stowers Institute for Medical Research, Kansas City, MO, USA." } }, { "@type": "Person", "name": "Andrea Guarracino", "url": "https://questionsmedicales.fr/author/Andrea%20Guarracino", "affiliation": { "@type": "Organization", "name": "Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Inadequate intakes of fatty acids attributed to the ultra-processed foods consumed by Portuguese population: The upper project.", "datePublished": "2024-07-14", "url": "https://questionsmedicales.fr/article/39174431", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.numecd.2024.07.003" } }, { "@type": "ScholarlyArticle", "name": "The Transdiagnostic Connectome Project: a richly phenotyped open dataset for advancing the study of brain-behavior relationships in psychiatry.", "datePublished": "2024-06-21", "url": "https://questionsmedicales.fr/article/38946958", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1101/2024.06.18.24309054" } }, { "@type": "ScholarlyArticle", "name": "Assessing the Outputs, Outcomes, and Impacts of Science Communication: A Quantitative Content Analysis of 128 Science Communication Projects.", "datePublished": "2024-06-17", "url": "https://questionsmedicales.fr/article/39450330", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10755470241253858" } }, { "@type": "ScholarlyArticle", "name": "Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022.", "datePublished": "2024-06-06", "url": "https://questionsmedicales.fr/article/38833409", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.15585/mmwr.ss7304a1" } }, { "@type": "ScholarlyArticle", "name": "Heavy Metal Concentration Estimation for Different Farmland Soils Based on Projection Pursuit and LightGBM with Hyperspectral Images.", "datePublished": "2024-05-20", "url": "https://questionsmedicales.fr/article/38794105", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/s24103251" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Chromosomes", "item": "https://questionsmedicales.fr/mesh/D002875" }, { "@type": "ListItem", "position": 5, "name": "Chromosomes de mammifère", "item": "https://questionsmedicales.fr/mesh/D033481" }, { "@type": "ListItem", "position": 6, "name": "Chromosomes humains", "item": "https://questionsmedicales.fr/mesh/D002877" }, { "@type": "ListItem", "position": 7, "name": "Chromosomes humains 13-15", "item": "https://questionsmedicales.fr/mesh/D002901" }, { "@type": "ListItem", "position": 8, "name": "Chromosomes humains de la paire 15", "item": "https://questionsmedicales.fr/mesh/D002884" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chromosomes humains de la paire 15 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chromosomes humains de la paire 15", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chromosomes humains de la paire 15", "description": "Comment diagnostiquer une anomalie du chromosome 15 ?\nQuels tests génétiques sont utilisés pour le chromosome 15 ?\nQuels signes cliniques indiquent une anomalie sur le chromosome 15 ?\nPeut-on détecter des anomalies chromosomiques in utero ?\nQuel rôle joue le conseil génétique dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Pilot+Projects&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chromosomes humains de la paire 15", "description": "Quels symptômes sont associés à la trisomie 15 ?\nComment se manifeste le syndrome de Prader-Willi ?\nQuels troubles sont liés à des anomalies du chromosome 15 ?\nLes anomalies du chromosome 15 affectent-elles le comportement ?\nQuels signes peuvent indiquer un syndrome d'Angelman ?", "url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Pilot+Projects&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chromosomes humains de la paire 15", "description": "Peut-on prévenir les anomalies chromosomiques ?\nQuel rôle joue le dépistage prénatal ?\nLes antécédents familiaux influencent-ils le risque ?\nComment le mode de vie peut-il affecter le risque ?\nLes vaccinations influencent-elles les anomalies chromosomiques ?", "url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Pilot+Projects&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chromosomes humains de la paire 15", "description": "Quels traitements sont disponibles pour le syndrome d'Angelman ?\nComment gérer les symptômes de la trisomie 15 ?\nY a-t-il des médicaments pour traiter les troubles liés au chromosome 15 ?\nQuel rôle joue la thérapie comportementale ?\nLes interventions précoces sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Pilot+Projects&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chromosomes humains de la paire 15", "description": "Quelles complications peuvent survenir avec le syndrome d'Angelman ?\nLes anomalies du chromosome 15 peuvent-elles affecter la santé physique ?\nY a-t-il des risques de maladies associées ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Pilot+Projects&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chromosomes humains de la paire 15", "description": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?\nLe tabagisme influence-t-il le risque d'anomalies ?\nL'exposition à des toxines est-elle un facteur de risque ?\nLes maladies maternelles influencent-elles le risque ?\nLe stress maternel a-t-il un impact sur le risque ?", "url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Pilot+Projects&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie du chromosome 15 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un caryotype ou une analyse génétique peut révéler des anomalies sur le chromosome 15." } }, { "@type": "Question", "name": "Quels tests génétiques sont utilisés pour le chromosome 15 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'analyse de l'ADN, le séquençage et les tests de microdélétions." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une anomalie sur le chromosome 15 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des retards de développement, des troubles du comportement ou des malformations peuvent indiquer une anomalie." } }, { "@type": "Question", "name": "Peut-on détecter des anomalies chromosomiques in utero ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests comme l'amniocentèse peuvent détecter des anomalies chromosomiques in utero." } }, { "@type": "Question", "name": "Quel rôle joue le conseil génétique dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le conseil génétique aide à comprendre les risques et les implications des anomalies chromosomiques." } }, { "@type": "Question", "name": "Quels symptômes sont associés à la trisomie 15 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des retards de développement, des problèmes d'apprentissage et des malformations." } }, { "@type": "Question", "name": "Comment se manifeste le syndrome de Prader-Willi ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Il se manifeste par une hyperphagie, un retard de développement et des problèmes hormonaux." } }, { "@type": "Question", "name": "Quels troubles sont liés à des anomalies du chromosome 15 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles comme l'autisme, le syndrome d'Angelman et le syndrome de Prader-Willi sont liés." } }, { "@type": "Question", "name": "Les anomalies du chromosome 15 affectent-elles le comportement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des troubles du comportement et des difficultés sociales." } }, { "@type": "Question", "name": "Quels signes peuvent indiquer un syndrome d'Angelman ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent des troubles de la marche, des rires inappropriés et des retards de langage." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies chromosomiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies ne peuvent pas être prévenues, mais le conseil génétique peut aider." } }, { "@type": "Question", "name": "Quel rôle joue le dépistage prénatal ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage prénatal permet d'identifier les risques d'anomalies chromosomiques chez le fœtus." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'anomalies chromosomiques augmentent le risque pour les descendants." } }, { "@type": "Question", "name": "Comment le mode de vie peut-il affecter le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut réduire certains risques, mais ne prévient pas toutes les anomalies." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles les anomalies chromosomiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccinations ne sont pas liées aux anomalies chromosomiques et sont sûres." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le syndrome d'Angelman ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie physique, l'orthophonie et des interventions comportementales." } }, { "@type": "Question", "name": "Comment gérer les symptômes de la trisomie 15 ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut des thérapies éducatives, comportementales et un suivi médical régulier." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour traiter les troubles liés au chromosome 15 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour gérer les symptômes comme l'anxiété ou l'hyperactivité." } }, { "@type": "Question", "name": "Quel rôle joue la thérapie comportementale ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elle aide à améliorer les compétences sociales et à gérer les comportements difficiles." } }, { "@type": "Question", "name": "Les interventions précoces sont-elles efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent améliorer le développement et la qualité de vie des enfants affectés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le syndrome d'Angelman ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des problèmes de sommeil, des troubles de l'alimentation et des crises." } }, { "@type": "Question", "name": "Les anomalies du chromosome 15 peuvent-elles affecter la santé physique ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des problèmes de croissance, d'obésité et des troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies associées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des risques de maladies comme le diabète et des troubles cardiovasculaires peuvent exister." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent réduire la qualité de vie en limitant les activités et en nécessitant des soins constants." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais beaucoup nécessitent un suivi à long terme." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge maternel avancé et des antécédents familiaux d'anomalies augmentent le risque." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque d'anomalies ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme pendant la grossesse peut augmenter le risque d'anomalies chromosomiques." } }, { "@type": "Question", "name": "L'exposition à des toxines est-elle un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines environnementales peut augmenter le risque d'anomalies." } }, { "@type": "Question", "name": "Les maladies maternelles influencent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies maternelles, comme le diabète, peuvent augmenter le risque d'anomalies chromosomiques." } }, { "@type": "Question", "name": "Le stress maternel a-t-il un impact sur le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un stress élevé pendant la grossesse peut influencer le développement fœtal et le risque d'anomalies." } } ] } ] }

Sources (10000 au total)

Inadequate intakes of fatty acids attributed to the ultra-processed foods consumed by Portuguese population: The upper project.

Population-based studies suggest an inverse relationship between the dietary share of ultra-processed foods (UPF), as defined by NOVA classification, and the overall dietary nutritional quality. Howev... Cross-sectional data from IAN-AF 2015-2016 were used for this study. Food consumption data were collected through two 24-h food recalls, and food items were classified according to the NOVA system. Fo... In this study the consumption of UPF was associated with a worse fatty acids profile in the Portuguese diet, adding evidence regarding the negative impact of UPF on diet quality....

Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022.

Elimination of tuberculosis (TB) is defined as reducing TB disease incidence in the United States to less than 1 case per million persons per year. In 2022, TB incidence in the United States was 2.5 T... The 5-year period for which the most recent data were available for each of five indicators: 1) overall TB incidence (2018-2022), 2) TB incidence among non-U.S.-born persons (2018-2022), 3) percentage... The National TB Indicators Project (NTIP) is a web-based performance monitoring tool that uses national TB surveillance data reported through the National TB Surveillance System and the Aggregate Repo... During the 5-year period for which the most recent data were available, most TB programs had improvements in reducing overall TB incidence (71.2%) and increasing the percentage of contacts receiving a... This report is the first to describe a 5-year relative change for TB program performance. These results suggest that TB programs are making improvements in activities that help identify persons with T... Use of NTIP data from individual TB programs enables a more detailed examination of trends in program performance and identification of areas for program improvement. Assessing indicator trends by TB ...

Diagnostic performance of chest CT average intensity projection (AIP) reconstruction for the assessment of pleuro-parenchymal abnormalities.

The comparison between chest x-ray (CXR) and computed tomography (CT) images is commonly required in clinical practice to assess the evolution of chest pathological manifestations. Intrinsic differenc... 142 patients who underwent chest CT examination and CXR within 24 hours were enrolled. CT was the standard of reference. Both conventional CXR (c-CXR) and s-CXR images were retrospectively reviewed fo... Overall, s-CXR sensitivity ranged 45-67% for consolidation, 12-28% for nodule/mass, 17-33% for linear opacities, 2-61% for reticular opacities, and 33-58% for pleural effusion; specificity 65-83%, 83-... S-CXR images, reconstructed with AIP technique, can be compared with conventional images in clinical practice and for educational purposes....

Blood donation projections using hierarchical time series forecasting: the case of Zimbabwe's national blood bank.

The discrepancy between blood supply and demand requires accurate forecasts of the blood supply at any blood bank. Accurate blood donation forecasting gives blood managers empirical evidence in blood ... The monthly blood donation data covering the period 2007 to 2018, collected from the National Blood Service Zimbabwe (NBSZ) was used. The data was disaggregated by gender and blood groups types within... Blood group O had the highest monthly yield mean of 1507.85 and 1230.03 blood units for male and female donors, respectively. The top-down forecasting proportions (TDFP) under ARIMA, with a MAPE value... The gradual decrease in future blood donations exhibited by the predictions calls for blood authorities in Zimbabwe to develop interventions that encourage blood donor retention and regular donations....

The Impact of Integrated Patient Education on Short-Term Revisit Rates in Healthcare Settings: A Quality Improvement Project.

Patient education plays a critical role in healthcare, influencing outcomes and resource utilization. However, effectively integrating patient education into clinical practice remains challenging due ... A quasi-experimental, pre-test/post-test design without a control group was employed at the International Medical Center in Riffa, Bahrain. The intervention consisted of modifications to the EHR syste... A total of 1,239 patients participated in the study, which was divided into two groups: 754 patients in the pre-intervention group and 485 patients in the post-intervention group. A significant change... Enhancements to EHR systems, combined with comprehensive staff education on patient education, can lead to significant reductions in short-term patient revisits. This underscores the importance of int...

Centring participant experience: a realist evaluation of a menstruator-friendly facility design project in a refugee settlement, Lebanon.

Menstrual health in humanitarian contexts is a neglected topic. Its taboo nature presents difficulties for participants in menstrual health projects in these particularly challenging settings. Namely,... The project studied was led by the International Federation of Red Cross and Red Crescent Societies who piloted their adaptable manual for menstruator-friendly water, sanitation and hygiene (WaSH) fac... The authors collected interview and focus group data on the contextual factors and processes within the project from nine project staff and 16 settlement inhabitants. They used a realist process of th... The contextual factors and causal mechanisms promoting participant experience comprised individual (choices influencing and experience during participation), interpersonal (group dynamics and the role... The research uses a case study from a renowned humanitarian organisation who provided a well-delivered project in a conducive environment to explore the mechanisms and contexts that can promote wider ...